AS
Asha Sampige Thontadarya
About Asha Sampige Thontadarya
Data last updated:
Asha Sampige Thontadarya is a Director at Celest Pharma Labs Private Limited (since 2014) and Director at Peenya Pharmaceuticals Private Limited (since 2023). The companies operate in Healthcare and Travel and Hospitality. The 2 current companies with reported revenue have a combined latest revenue of ₹16.21 Cr; the largest is Celest Pharma Labs Private Limited at ₹11.91 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Celest Pharma Labs Private Limited U24230KA2010PTC052859 | Director | 04 Mar 2014 | 2010 | ₹11.91 Cr (FY 2025) | Active |
 Peenya Pharmaceuticals Private Limited U74999KA2016PTC094826 | Director | 27 Mar 2023 | 2016 | ₹4.30 Cr (FY 2025) | Active |
Board colleagues of Asha Sampige Thontadarya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arun Shivamurthaiah Mathad | 02870427 | Celest Pharma Labs Private Limited , Peenya Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Asha Sampige Thontadarya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asha Sampige Thontadarya
Asha Sampige Thontadarya currently holds 2 directorships: Celest Pharma Labs Private Limited (Director, since 04 Mar 2014, revenue ₹11.91 Cr (FY 2025)); Peenya Pharmaceuticals Private Limited (Director, since 27 Mar 2023, revenue ₹4.30 Cr (FY 2025)).
Asha Sampige Thontadarya was first appointed on 04 Mar 2014 as Director at Celest Pharma Labs Private Limited. The most recent appointment on record is 27 Mar 2023 at Peenya Pharmaceuticals Private Limited.
The 2 current companies of Asha Sampige Thontadarya that report revenue have a combined latest revenue of ₹16.21 Cr: Celest Pharma Labs Private Limited ₹11.91 Cr (FY 2025); Peenya Pharmaceuticals Private Limited ₹4.30 Cr (FY 2025).
The current boards of Asha Sampige Thontadarya's companies include Arun Shivamurthaiah Mathad (Celest Pharma Labs Private Limited).